CGD Analysis Examines Entrepreneurialism In Pharmacy, Supply Chain Markets In Transitional LMICs

Center for Global Development: Entrepreneurship on the Rise in the Medical Supply Chain in Africa: A Tale of Four Pharmacy Disruptors
In this analysis, Cassandra Nemzoff, research assistant with CGD Europe, Dan Rosen of AfRx Consulting Group, and Kalipso Chalkidou, director of global health policy and senior fellow at CGD, “look at how … entrepreneurialism is being leveraged in the pharmacy and supply chain space. … [W]e chronicle what we describe as the 4M’s — Maisha Meds, MedSource, mPharma, and mTIBA — and the impact we think they could have on the procurement and supply chain landscape in low-and middle-income countries (LMICs) in transition, and perhaps even in high-income country markets also struggling with spiraling drug costs…” (11/7).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.